BlackRock’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BlackRock’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-419,357	Closed	-$3.65M	–	5157
2018 Q2	$3.65M	Sell	419,357 -185,559	-31%	-$1.67M	﹤0.01%	3570
2018 Q1	$6.14M	Sell	604,916 -104,497	-15%	-$878K	﹤0.01%	3349
2017 Q4	$3.44M	Sell	709,413 -27,347	-4%	-$133K	﹤0.01%	3545
2017 Q3	$3.35M	Sell	736,760 -5,546	-0.7%	-$26K	﹤0.01%	3581
2017 Q2	$3.75M	Buy	742,306 +84,912	+13%	+$380K	﹤0.01%	3547
2017 Q1	$3.12M	Buy	+657,394	New	+$3.32M	﹤0.01%	3529

BlackRock's JNP Position: Q3 2018 in Review

BlackRock sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 419,357 shares — an estimated $3.65M sold.

BlackRock first reported a position in JNP in Q1 2017 and held it in 6 quarters. The position peaked at $6.14M in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

BlackRock reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
BlackRock sold 419,357 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $3.65M.
BlackRock first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 6 quarters.
BlackRock's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $6.14M in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on BlackRock's 13F filing for Q3 2018, filed 9 Nov 2018.